Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer

April 30, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related disease, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its lead candidate, Telomir-Zn, for the treatment of patients with advanced or...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

April 30, 2026 7:20 AM

Ascelia Pharma (STO:ACE):During April, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the directed new issue of ordinary shares which was announced by Ascelia Pharma on 23 April 2026. As of 30 April 2026, the total number of shares in Ascelia Pharma amounts to 134,569,246 shares, whereof 133,535,460 are ordinary shares with one vote each and 1,033,786 are series C shares with 1/10 vote...

Read more

Adjusted Timeline for the Previously Communicated Rights Issue

April 30, 2026 6:30 AM

AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announces that the timeline for the previously communicated rights issue of approximately SEK 30.1 million is being adjusted due to technical issuance reasons. All terms of the Rights Issue, including the subscription price of SEK...

Read more

Wall Pilates Emerges as a Leading Home Workout Trend in the Digital Wellness Boom

April 30, 2026 6:20 AM

Wall Pilates, As the global wellness industry continues to expand, consumers are increasingly prioritizing convenient and adaptable fitness solutions that can be performed from home. Among the trends gaining traction is wall-based Pilates, a variation of traditional Pilates exercises that utilizes a wall for support, stability, and resistance. This approach to fitness is attracting attention from both beginners and experienced practitioners...

Read more

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

April 30, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company will release results for its first quarter of 2026, ended March 31, 2026, after the market closes on Thursday, May 7, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can also...

Read more

Evotec Receives Grants to Advance Tuberculosis Treatment

April 30, 2026 3:20 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that it has received two grants from the Gates Foundation for drug discovery and translation in tuberculosis (TB), following four earlier TB grants from the foundation, amounting to $4.9 million over 25 months and $5 million over 24 months. The new funding underscores Evotec's commitment to translating innovative science into impactful therapies addressing high-priority public...

Read more

IRLAB: Invitation to the Interim Report for Q1 2026 Presentation and Webcast

April 30, 2026 3:15 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January - March 2026. The interim report will be published on Wednesday, May 6, 2026, at 07:00 CEST.The presentation will be held on May 6,...

Read more

Theralogix Introduces AndroSyn: An Evidence-Based Supplement Formulated to Improve Testosterone Levels*

April 30, 2026 12:00 AM

Theralogix, a trusted leader in nutritional supplements, is proud to announce the launch of AndroSyn™, a scientifically formulated supplement designed to support healthy testosterone levels and promote overall men's health and vitality.*Testosterone plays a crucial role in men's health, influencing muscle strength, energy levels, mood, mental clarity, and overall physical performance.* As men age, maintaining healthy testosterone levels becomes...

Read more

CMS Is Quietly Pushing Unvalidated Hemp -Marijuana Products on America's Elderly - and Calling It Healthcare

April 29, 2026 11:42 PM

Somewhere in America right now, a Medicare patient over 65 - perhaps managing cancer, perhaps on blood thinners, perhaps already navigating a complex medication regimen - may be offered a hemp-derived cannabinoid product through their federally sponsored health program. Not because a doctor prescribed it after a clinical evaluation. Not because the FDA approved it. Not because a single randomized controlled trial has demonstrated it is safe or...

Read more

Healthcare Innovator and Strategist Executes Multimillion-Dollar Acquisition of Pediatric Asset

April 29, 2026 11:10 PM

Rajesh Nandipaty, a Master of Healthcare Innovation (MHI) graduate, successfully facilitated the multimillion-dollar acquisition and strategic transition of a landmark pediatric clinic in Weslaco, Texas. The transaction, finalized in January 2025, marks a sophisticated exit for the founding pediatrician and secures the facility's role as a cornerstone of regional specialized care. The acquisition centered on a high-spec commercial facility...

Read more

Cornerstone Specialty Network and Knowtex Announce Strategic Partnership to Advance AI-Driven Clinical Workflows and Operational Efficiency Nationwide

April 29, 2026 1:40 PM

Cornerstone Specialty Network ("Cornerstone"), a leading national network of community oncology and multispecialty practices, today announced a strategic partnership with Knowtex, a healthcare technology company specializing in voice-enabled AI solutions designed to automate clinical workflows and improve operational performance.Through this partnership, Cornerstone and Knowtex will deploy advanced voice AI technology across the network to...

Read more

IRLAB publishes the Annual Report for 2025

April 29, 2026 10:50 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that the Annual Report for 2025 is published on the company's website, www.irlab.se.IRLAB has published the Annual Report 2025 for the financial year, which covers January 1 to December 31, 2025. The Annual Report is available, in Swedish, on IRLAB's website: Financial reports - IRLAB. (The Annual Report...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Snapshot Recipes Redesign with Advanced AI, Beverage Integration, and Smart Cookbook Features

April 29, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced a major upgrade to its AI-powered mobile recipe application, Snapshot Recipes, featuring a redesigned user interface, expanded recipe generation capabilities, and enhanced user-focused tools.The latest update introduces a more refined and visually engaging experience, with elegant design improvements aimed at increasing usability, engagement, and overall user...

Read more

CVS Pharmacy Makes Cold & Cough Relief Easier With Delivery Straight to Your Door

April 29, 2026 9:00 AM

Originally published on CVS Health Company NewsKey pointsCVS Pharmacy is now offering same-day delivery of over-the-counter medications containing pseudoephedrine (PSE) or ephedrine (EPH) in select states, where allowed by law.The convenient new offering gives customers the ability to purchase cold and cough medicines containing the ingredients online and delivered to their home.Now, more than ever, getting relief doesn't have to mean leaving...

Read more

GAT Sport Introduces Nitraflex(R) Performance Pre-Workout Chews, a Breakthrough Format Designed to Reignite the Pre-Workout Category

April 29, 2026 9:00 AM

GAT Sport (www.gatsport.com), a sports nutrition company trusted by serious athletes for more than 25 years, today announced Nitraflex® Performance Pre-Workout Chews, a new chewable pre-workout tablet designed to deliver powder-level performance through a patent-pending delivery system that may help ingredients take effect faster. Unlike pre-workout and energy drinks that sit in your stomach before kicking in, Nitraflex Performance Pre-Workout...

Read more

KeepWOL Announces Expansion Into Healthcare Following Clinical Collaboration With Academic Medical Center

April 29, 2026 9:00 AM

KeepWOL, an AI-powered team effectiveness platform that helps organizations build belonging and measure team performance, today announced its formal expansion into the healthcare market following a year-long collaboration with a large academic medical center. The platform was deployed in partnership with physician leadership to support an initiative to strengthen belonging and team performance across clinical teams.The expansion comes at a...

Read more

Senzime Strengthens U.S. Operations with New Leadership Appointments

April 29, 2026 8:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced new appointments to its Global Executive Leadership Team, including the recruitment of a new Vice President of U.S. Sales and the appointment of a Vice President of Clinical and Medical Affairs.Josi Wood, MBA, has been recruited to strengthen the company's U.S. commercial operations as Vice President of U.S. Sales, assuming a newly created leadership role within Senzime. Josi is an...

Read more

Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

April 29, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced topline results from the completion of its effectiveness trial of crofelemer (FDA conditionally approved Canalevia-CA1) for the treatment of chemotherapy-induced diarrhea (CID) in dogs. The statistically significant results demonstrated that dogs suffering from CID that were treated with Canalevia-CA1 twice daily at the onset of diarrhea had, at the end of 3 days of treatment, an average...

Read more

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

April 29, 2026 8:30 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery, today announced that Jeb Besser, CEO of Modular Medical, will present at Tribe Public's Webinar Presentation and Q&A Event titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." The event is scheduled to begin at 8 a.m. pacific / 11 a.m. eastern on Friday, May 1, 2026. To register to join the...

Read more

Shape Ophthalmics Expands Global Access to Advanced Eye Examination Equipment for Eye Care Professionals

April 29, 2026 7:10 AM

Shape Ophthalmics, a leading supplier of ophthalmic and optometry equipment, today announced the continued expansion of its global distribution platform, providing eye care professionals with access to advanced diagnostic technologies across Asia and international markets.Founded by a team of experienced ophthalmologists, optometrists, and opticians, Shape Ophthalmics was established to address the need for a reliable, high-quality source of eye...

Read more